Dissection of NADPH-cytochrome P450 oxidoreductase into distinct functional domains.

Por Smith, G C, Tew, D G, Wolf, C R
Publicado em 1994

Studies on the inhibitory mechanism of iodonium compounds with special reference to neutrophil NADPH oxidase.

Por O'Donnell, B V, Tew, D G, Jones, O T, England, P J
Publicado em 1993

Expression, purification and characterization of a human serine-dependent phospholipase A2 with high specificity for oxidized phospholipids and platelet activating factor.

Por Rice, S Q, Southan, C, Boyd, H F, Terrett, J A, MacPhee, C H, Moores, K, Gloger, I S, Tew, D G
Publicado em 1998

Crystal structure of the FMN-binding domain of human cytochrome P450 reductase at 1.93 A resolution.

Por Zhao, Q., Modi, S., Smith, G., Paine, M., McDonagh, P. D., Wolf, C. R., Tew, D., Lian, L. Y., Roberts, G. C., Driessen, H. P.
Publicado em 1999

The role of ATP citrate-lyase in the metabolic regulation of plasma lipids. Hypolipidaemic effects of SB-204990, a lactone prodrug of the potent ATP citrate-lyase inhibitor SB-2010...

Por Pearce, N J, Yates, J W, Berkhout, T A, Jackson, B, Tew, D, Boyd, H, Camilleri, P, Sweeney, P, Gribble, A D, Shaw, A, Groot, P H
Publicado em 1998

Lipoprotein-associated phospholipase A2, platelet-activating factor acetylhydrolase, generates two bioactive products during the oxidation of low-density lipoprotein: use of a nove...

Por MacPhee, C H, Moores, K E, Boyd, H F, Dhanak, D, Ife, R J, Leach, C A, Leake, D S, Milliner, K J, Patterson, R A, Suckling, K E, Tew, D G, Hickey, D M
Publicado em 1999